CA2446400C - Implant osseux et procede de fabrication associe - Google Patents

Implant osseux et procede de fabrication associe Download PDF

Info

Publication number: CA2446400C
Authority: CA; Canada
Prior art keywords: bone; osteoimplant; derived elements; derived; elements
Prior art date: 1998-02-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA002446400A

Other languages

English (en)

Other versions

CA2446400A1 (fr

Inventor

Todd M. Boyce

Albert Manrique

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Warsaw Orthopedic Inc

Original Assignee

Osteotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-06

Filing date

1999-02-05

Publication date

2009-04-28

1998-02-06 Priority claimed from US09/020,205 external-priority patent/US6123731A/en

1999-02-05 Application filed by Osteotech Inc filed Critical Osteotech Inc

1999-08-12 Publication of CA2446400A1 publication Critical patent/CA2446400A1/fr

2009-04-28 Application granted granted Critical

2009-04-28 Publication of CA2446400C publication Critical patent/CA2446400C/fr

2019-02-05 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 35
238000004519 manufacturing process Methods 0.000 title claims abstract description 8
210000000988 bone and bone Anatomy 0.000 claims abstract description 158
239000000126 substance Substances 0.000 claims abstract description 48
229920001436 collagen Polymers 0.000 claims abstract description 45
102000008186 Collagen Human genes 0.000 claims abstract description 44
108010035532 Collagen Proteins 0.000 claims abstract description 44
239000000463 material Substances 0.000 claims abstract description 15
239000007943 implant Substances 0.000 claims abstract description 12
239000007787 solid Substances 0.000 claims abstract description 11
230000008468 bone growth Effects 0.000 claims abstract description 10
230000001939 inductive effect Effects 0.000 claims abstract description 7
230000001054 cortical effect Effects 0.000 claims description 19
239000003795 chemical substances by application Substances 0.000 claims description 16
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
239000002245 particle Substances 0.000 claims description 12
238000011282 treatment Methods 0.000 claims description 12
238000010382 chemical cross-linking Methods 0.000 claims description 11
239000003431 cross linking reagent Substances 0.000 claims description 11
239000000835 fiber Substances 0.000 claims description 11
-1 oxygen ions Chemical class 0.000 claims description 10
108700039882 Protein Glutamine gamma Glutamyltransferase 2 Proteins 0.000 claims description 7
102100038095 Protein-glutamine gamma-glutamyltransferase 2 Human genes 0.000 claims description 7
238000007493 shaping process Methods 0.000 claims description 6
239000000945 filler Substances 0.000 claims description 5
230000003014 reinforcing effect Effects 0.000 claims description 5
102000004190 Enzymes Human genes 0.000 claims description 4
108090000790 Enzymes Proteins 0.000 claims description 4
230000015572 biosynthetic process Effects 0.000 claims description 4
230000006835 compression Effects 0.000 claims description 4
238000007906 compression Methods 0.000 claims description 4
230000002255 enzymatic effect Effects 0.000 claims description 4
235000000346 sugar Nutrition 0.000 claims description 4
150000008163 sugars Chemical class 0.000 claims description 4
150000001875 compounds Chemical class 0.000 claims description 3
230000036571 hydration Effects 0.000 claims description 3
238000006703 hydration reaction Methods 0.000 claims description 3
230000001404 mediated effect Effects 0.000 claims description 3
239000001301 oxygen Substances 0.000 claims description 3
229910052760 oxygen Inorganic materials 0.000 claims description 3
238000007539 photo-oxidation reaction Methods 0.000 claims description 3
229920000642 polymer Polymers 0.000 claims description 3
102000004169 proteins and genes Human genes 0.000 claims description 3
108090000623 proteins and genes Proteins 0.000 claims description 3
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 2
239000005057 Hexamethylene diisocyanate Substances 0.000 claims description 2
150000001299 aldehydes Chemical class 0.000 claims description 2
238000010438 heat treatment Methods 0.000 claims description 2
RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 claims description 2
229910044991 metal oxide Inorganic materials 0.000 claims description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 2
235000013824 polyphenols Nutrition 0.000 claims description 2
239000001648 tannin Substances 0.000 claims description 2
235000018553 tannin Nutrition 0.000 claims description 2
229920001864 tannin Polymers 0.000 claims description 2
210000004197 pelvis Anatomy 0.000 claims 2
230000001413 cellular effect Effects 0.000 claims 1
239000003102 growth factor Substances 0.000 claims 1
150000002484 inorganic compounds Chemical class 0.000 claims 1
229910010272 inorganic material Inorganic materials 0.000 claims 1
230000001678 irradiating effect Effects 0.000 claims 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
239000000243 solution Substances 0.000 description 18
238000004132 cross linking Methods 0.000 description 8
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 7
230000035876 healing Effects 0.000 description 6
210000004027 cell Anatomy 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
238000005115 demineralization Methods 0.000 description 5
230000002328 demineralizing effect Effects 0.000 description 5
125000000524 functional group Chemical group 0.000 description 5
239000000843 powder Substances 0.000 description 5
238000001356 surgical procedure Methods 0.000 description 5
210000001519 tissue Anatomy 0.000 description 5
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
210000002805 bone matrix Anatomy 0.000 description 4
230000004927 fusion Effects 0.000 description 4
239000000203 mixture Substances 0.000 description 4
230000008439 repair process Effects 0.000 description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
239000000853 adhesive Substances 0.000 description 3
230000001070 adhesive effect Effects 0.000 description 3
235000001014 amino acid Nutrition 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
230000000890 antigenic effect Effects 0.000 description 3
230000002599 biostatic effect Effects 0.000 description 3
239000003814 drug Substances 0.000 description 3
238000002513 implantation Methods 0.000 description 3
229910052500 inorganic mineral Inorganic materials 0.000 description 3
239000011707 mineral Substances 0.000 description 3
230000007935 neutral effect Effects 0.000 description 3
230000000278 osteoconductive effect Effects 0.000 description 3
239000004014 plasticizer Substances 0.000 description 3
229920001223 polyethylene glycol Polymers 0.000 description 3
239000011148 porous material Substances 0.000 description 3
210000000689 upper leg Anatomy 0.000 description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
206010017076 Fracture Diseases 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
102000013275 Somatomedins Human genes 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000002491 angiogenic effect Effects 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
238000011882 arthroplasty Methods 0.000 description 2
230000003416 augmentation Effects 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
239000003139 biocide Substances 0.000 description 2
239000012620 biological material Substances 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
210000000845 cartilage Anatomy 0.000 description 2
239000000470 constituent Substances 0.000 description 2
230000007547 defect Effects 0.000 description 2
229940079593 drug Drugs 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
150000002170 ethers Chemical class 0.000 description 2
239000012634 fragment Substances 0.000 description 2
239000008103 glucose Substances 0.000 description 2
239000010439 graphite Substances 0.000 description 2
229910002804 graphite Inorganic materials 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000003754 machining Methods 0.000 description 2
230000013011 mating Effects 0.000 description 2
230000002188 osteogenic effect Effects 0.000 description 2
210000003455 parietal bone Anatomy 0.000 description 2
230000001936 parietal effect Effects 0.000 description 2
230000035515 penetration Effects 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
235000018102 proteins Nutrition 0.000 description 2
239000002296 pyrolytic carbon Substances 0.000 description 2
210000003625 skull Anatomy 0.000 description 2
238000003756 stirring Methods 0.000 description 2
210000000115 thoracic cavity Anatomy 0.000 description 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
ODURFHDFZAVGHC-KTKRTIGZSA-N (z)-2-aminooctadec-9-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCC(N)C(O)=O ODURFHDFZAVGHC-KTKRTIGZSA-N 0.000 description 1
KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
241000370685 Arge Species 0.000 description 1
108010001478 Bacitracin Proteins 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
102000029816 Collagenase Human genes 0.000 description 1
108060005980 Collagenase Proteins 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
239000004348 Glyceryl diacetate Substances 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
102000018997 Growth Hormone Human genes 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
206010023509 Kyphosis Diseases 0.000 description 1
208000007623 Lordosis Diseases 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
208000002565 Open Fractures Diseases 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
108010093965 Polymyxin B Proteins 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
208000020339 Spinal injury Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
102000009618 Transforming Growth Factors Human genes 0.000 description 1
108010009583 Transforming Growth Factors Proteins 0.000 description 1
108060008539 Transglutaminase Proteins 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
108010015940 Viomycin Proteins 0.000 description 1
OZKXLOZHHUHGNV-UHFFFAOYSA-N Viomycin Natural products NCCCC(N)CC(=O)NC1CNC(=O)C(=CNC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC1=O)C2CC(O)NC(=N)N2 OZKXLOZHHUHGNV-UHFFFAOYSA-N 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
VXAUWWUXCIMFIM-UHFFFAOYSA-M aluminum;oxygen(2-);hydroxide Chemical compound [OH-].[O-2].[Al+3] VXAUWWUXCIMFIM-UHFFFAOYSA-M 0.000 description 1
210000001909 alveolar process Anatomy 0.000 description 1
239000002280 amphoteric surfactant Substances 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
239000003945 anionic surfactant Substances 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
208000037873 arthrodesis Diseases 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
150000001510 aspartic acids Chemical class 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
229940073066 azactam Drugs 0.000 description 1
WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
229960003071 bacitracin Drugs 0.000 description 1
229930184125 bacitracin Natural products 0.000 description 1
CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
239000000227 bioadhesive Substances 0.000 description 1
239000003462 bioceramic Substances 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
239000005312 bioglass Substances 0.000 description 1
230000036770 blood supply Effects 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
210000000459 calcaneus Anatomy 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
210000003010 carpal bone Anatomy 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
239000003093 cationic surfactant Substances 0.000 description 1
229960001139 cefazolin Drugs 0.000 description 1
MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
230000003399 chemotactic effect Effects 0.000 description 1
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
229940097572 chloromycetin Drugs 0.000 description 1
210000001612 chondrocyte Anatomy 0.000 description 1
229940090961 chromium dioxide Drugs 0.000 description 1
IAQWMWUKBQPOIY-UHFFFAOYSA-N chromium(4+);oxygen(2-) Chemical compound [O-2].[O-2].[Cr+4] IAQWMWUKBQPOIY-UHFFFAOYSA-N 0.000 description 1
AYTAKQFHWFYBMA-UHFFFAOYSA-N chromium(IV) oxide Inorganic materials O=[Cr]=O AYTAKQFHWFYBMA-UHFFFAOYSA-N 0.000 description 1
210000003109 clavicle Anatomy 0.000 description 1
229960002227 clindamycin Drugs 0.000 description 1
KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229960002424 collagenase Drugs 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
238000010276 construction Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000003436 cytoskeletal effect Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000006735 deficit Effects 0.000 description 1
YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
150000002081 enamines Chemical class 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000005886 esterification reaction Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000000284 extract Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
210000000968 fibrocartilage Anatomy 0.000 description 1
210000002082 fibula Anatomy 0.000 description 1
238000011049 filling Methods 0.000 description 1
239000012467 final product Substances 0.000 description 1
239000007789 gas Substances 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
150000002307 glutamic acids Chemical class 0.000 description 1
235000019443 glyceryl diacetate Nutrition 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
210000001624 hip Anatomy 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
210000004095 humeral head Anatomy 0.000 description 1
210000002758 humerus Anatomy 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
229960003160 hyaluronic acid Drugs 0.000 description 1
GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
229910052588 hydroxylapatite Inorganic materials 0.000 description 1
210000003692 ilium Anatomy 0.000 description 1
238000007654 immersion Methods 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
238000009434 installation Methods 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
210000002239 ischium bone Anatomy 0.000 description 1
238000002684 laminectomy Methods 0.000 description 1
239000012633 leachable Substances 0.000 description 1
230000036244 malformation Effects 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
210000004373 mandible Anatomy 0.000 description 1
210000002050 maxilla Anatomy 0.000 description 1
210000002901 mesenchymal stem cell Anatomy 0.000 description 1
210000000236 metacarpal bone Anatomy 0.000 description 1
150000001455 metallic ions Chemical class 0.000 description 1
210000001872 metatarsal bone Anatomy 0.000 description 1
238000003801 milling Methods 0.000 description 1
230000000921 morphogenic effect Effects 0.000 description 1
238000000465 moulding Methods 0.000 description 1
229940105132 myristate Drugs 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
230000000399 orthopedic effect Effects 0.000 description 1
230000011164 ossification Effects 0.000 description 1
230000002138 osteoinductive effect Effects 0.000 description 1
238000012856 packing Methods 0.000 description 1
210000004738 parenchymal cell Anatomy 0.000 description 1
210000004417 patella Anatomy 0.000 description 1
239000008188 pellet Substances 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
239000004926 polymethyl methacrylate Substances 0.000 description 1
229920000024 polymyxin B Polymers 0.000 description 1
229960005266 polymyxin b Drugs 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229940069328 povidone Drugs 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
210000003689 pubic bone Anatomy 0.000 description 1
210000002320 radius Anatomy 0.000 description 1
238000011160 research Methods 0.000 description 1
210000000614 rib Anatomy 0.000 description 1
210000001991 scapula Anatomy 0.000 description 1
206010039722 scoliosis Diseases 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000002002 slurry Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
206010062261 spinal cord neoplasm Diseases 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
210000001562 sternum Anatomy 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
229940041022 streptomycins Drugs 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
210000001738 temporomandibular joint Anatomy 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
229940040944 tetracyclines Drugs 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
210000002303 tibia Anatomy 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
229960000707 tobramycin Drugs 0.000 description 1
NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
102000003601 transglutaminase Human genes 0.000 description 1
230000014616 translation Effects 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
229940078499 tricalcium phosphate Drugs 0.000 description 1
229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
235000019731 tricalcium phosphate Nutrition 0.000 description 1
210000000623 ulna Anatomy 0.000 description 1
230000002792 vascular Effects 0.000 description 1
229950001272 viomycin Drugs 0.000 description 1
GXFAIFRPOKBQRV-GHXCTMGLSA-N viomycin Chemical compound N1C(=O)\C(=C\NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@@H](N)CCCN)CNC(=O)[C@@H]1[C@@H]1NC(=N)N[C@@H](O)C1 GXFAIFRPOKBQRV-GHXCTMGLSA-N 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
238000003466 welding Methods 0.000 description 1
150000003754 zirconium Chemical class 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/365—Bones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Botany (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Zoology (AREA)
Materials For Medical Uses (AREA)
Prostheses (AREA)

CA002446400A 1998-02-06 1999-02-05 Implant osseux et procede de fabrication associe Expired - Fee Related CA2446400C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US09/020,205 US6123731A (en)	1998-02-06	1998-02-06	Osteoimplant and method for its manufacture
US09/020,205		1998-02-06
CA002320481A CA2320481A1 (fr)	1998-02-06	1999-02-05	Implant osseux et procede de fabrication associe

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002320481A Division CA2320481A1 (fr)	1998-02-06	1999-02-05	Implant osseux et procede de fabrication associe

Publications (2)

Publication Number	Publication Date
CA2446400A1 CA2446400A1 (fr)	1999-08-12
CA2446400C true CA2446400C (fr)	2009-04-28

Family

ID=30116403

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002446400A Expired - Fee Related CA2446400C (fr)	1998-02-06	1999-02-05	Implant osseux et procede de fabrication associe

Country Status (1)

Country	Link
CA (1)	CA2446400C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US12311076B1 (en)	2018-06-07	2025-05-27	Seaspine, Inc.	Demineralized bone matrix composition with enhanced osteoinductivity and osteoconductivity

1999
- 1999-02-05 CA CA002446400A patent/CA2446400C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2446400A1 (fr)	1999-08-12

Legal Events

Date	Code	Title	Description
2003-11-12	EEER	Examination request
2016-03-19	MKLA	Lapsed	Effective date: 20160205

Publication	Publication Date	Title
US6843807B1 (en)	2005-01-18	Osteoimplant
US5899939A (en)	1999-05-04	Bone-derived implant for load-supporting applications
CA2363153C (fr)	2011-04-26	Implant osseux porteur, son procede de fabrication et procede de reparation d'un os a l'aide de cet implant osseux
US8133421B2 (en)	2012-03-13	Methods of making shaped load-bearing osteoimplant
US6696073B2 (en)	2004-02-24	Shaped load-bearing osteoimplant and methods of making same
US7001551B2 (en)	2006-02-21	Method of forming a composite bone material implant
US6478825B1 (en)	2002-11-12	Implant, method of making same and use of the implant for the treatment of bone defects
US20070233272A1 (en)	2007-10-04	Shaped load-bearing osteoimplant and methods of making same
CA2355046A1 (fr)	2000-06-22	Greffe osseuse et procede de regeneration osseuse guidee
CA2446400C (fr)	2009-04-28	Implant osseux et procede de fabrication associe
KR100608305B1 (ko)	2006-08-02	하중-지지용 골유도 임플란트
MXPA00007606A (en)	2001-07-31	Osteoimplant and method for its manufacture
CZ20002866A3 (cs)	2001-01-17	Kostní implantát